Dyadic to Present at H.C. Wainwright 23rd Annual Global Investment Conference

JUPITER, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying, and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and therapeutics at flexible commercial scales, today announced that the Company’s management will be attending and presenting at the following upcoming virtual investor event:

Event Details
Presenter: Mark Emalfarb, CEO

Date: Monday, September 13, 2021
Time: 7:00 AM Eastern Time – Presentation will also be available on demand during the conference September 13 – 15, 2021
Event Link: https://hcwevents.com/annualconference/

Dyadic management will be available during the event for one-one-one meetings. Interested investors may request a one-on-one meeting at hzosiak@dyadic.com or contact Dyadic at (561) 743-8333.

About Dyadic International, Inc.

Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical protein production platform based on the fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila), named C1. The C1 microorganism, which enables the development and large-scale manufacture of low cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles (VLPs) and antigens, monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. Certain other research activities are ongoing which include the exploration of using C1 to develop and produce certain metabolites and other biologic products. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in development and manufacture of biopharmaceuticals. In particular, as the aging population grows in developed and undeveloped countries, Dyadic believes the C1 technology may help bring biologic vaccines, drugs and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers, and improve access and cost to patients and the healthcare system, but most importantly save lives.

Please visit Dyadic’s website at http://www.dyadic.com/ for additional information, including details regarding Dyadic’s plans for its biopharmaceutical business.

About the author

Brent Dixon is the owner of E-Crypto News and an early adopter of cryptocurrencies. He is a Book editor- that has edited numerous books on Cryptocurrencies. He has been a writer for more than 30 years. Covering everything from Jazz Music to Blockchain Technology. He currently lives with his wife on Miami Beach, Fl.

Related Posts

E-Crypto News Executive Interviews



bitcoin
Bitcoin (BTC) $ 63,375.00
ethereum
Ethereum (ETH) $ 4,241.23
binance-coin
Binance Coin (BNB) $ 488.52
tether
Tether (USDT) $ 1.01
cardano
Cardano (ADA) $ 2.16
solana
Solana (SOL) $ 212.70
xrp
XRP (XRP) $ 1.10
polkadot
Polkadot (DOT) $ 44.82
dogecoin
Dogecoin (DOGE) $ 0.266781
usd-coin
USD Coin (USDC) $ 1.01
USD
EUR
GBP
bitcoinBitcoin (BTC)
$ 63,375.00
ethereumEthereum (ETH)
$ 4,241.23
tetherTether (USDT)
$ 1.01
bitcoin-cashBitcoin Cash (BCH)
$ 624.19
litecoinLitecoin (LTC)
$ 196.50
bitcoinBitcoin (BTC)
54.414,03
ethereumEthereum (ETH)
3.641,54
tetherTether (USDT)
0,867190
bitcoin-cashBitcoin Cash (BCH)
535,93
litecoinLitecoin (LTC)
168,72
bitcoinBitcoin (BTC)
46,055.75
ethereumEthereum (ETH)
3,082.18
tetherTether (USDT)
0.733985
bitcoin-cashBitcoin Cash (BCH)
453.61
litecoinLitecoin (LTC)
142.80

Automated trading with HaasBot Crypto Trading Bots

Crypto Scams

Behind The Scenes: How this Crypto Community Responded to + $50m Hack
October 18, 2021
Crypto Scams
Crypto Scams Still Persistent In 2021, SEC Warns About Red Flags To Watch
September 9, 2021
Poly Network
Here’s How Hackers Stole Over $600 million in the Poly Network Attack
August 12, 2021
The World’s Most Infamous Crypto Hacks and Scams
July 31, 2021
Cryptocurrency Exchanges
Cryptocurrency Exchanges and the Plague of Scams and Bans
June 29, 2021

Blockchain/Cryptocurrency Questions and Answers

ICo Presale
The Science Behind ICO Presales…
October 14, 2021
Beginner’s Guide to Investing in Cryptocurrency
August 9, 2021
Short-Sell Cryptocurrency
How to Short-Sell Cryptocurrency: A Brief Overview
July 17, 2021
Klaytn
What Is Klaytn (KLAY) And How Does It Work?
July 16, 2021
Cryptocurrencies
Our Crypto Roundup Interview Asks- Do Cryptocurrencies Have a Future?
July 15, 2021


CryptoCurrencyUSDChange 1hChange 24hChange 7d
Bitcoin63,264 0.27 % 3.80 % 2.73 %
Ethereum4,233.4 0.73 % 3.86 % 9.84 %
Binance Coin485.32 0.15 % 1.92 % 3.13 %
Tether0.9986 0.03 % 0.08 % 0.23 %
Cardano2.160 0.22 % 1.71 % 0.05 %
Solana212.26 0.49 % 5.30 % 32.78 %
XRP1.100 0.19 % 1.19 % 0.33 %
Polkadot30.87 2.19 % 17.29 % 10.73 %
Dogecoin0.2651 0.07 % 1.03 % 11.41 %
USD Coin1.000 0.14 % 0.20 % 0.17 %

bitcoin
Bitcoin (BTC) $ 63,375.00
ethereum
Ethereum (ETH) $ 4,241.23
binance-coin
Binance Coin (BNB) $ 488.52
tether
Tether (USDT) $ 1.01
cardano
Cardano (ADA) $ 2.16
solana
Solana (SOL) $ 212.70
xrp
XRP (XRP) $ 1.10
polkadot
Polkadot (DOT) $ 44.82
dogecoin
Dogecoin (DOGE) $ 0.266781
usd-coin
USD Coin (USDC) $ 1.01